Volume 115, Issue 1 pp. 90-95
Research Article

Heterotopic vascularized lymph node transfer to the medial calf without a skin paddle for restoration of lymphatic function: Proof of concept

Mark L. Smith MD

Corresponding Author

Mark L. Smith MD

Division of Plastic Surgery, Mount Sinai Beth Israel, New York, New York

Correspondence to: Mark L. Smith, MD, FACS, Division of Plastic Surgery, Mount Sinai Beth Israel, 10 Union Square East, Suite 2L, New York, NY 10003. Fax: +212-844-8798. E-mail: [email protected]

Search for more papers by this author
Bianca J. Molina MD

Bianca J. Molina MD

Division of Plastic Surgery, Mount Sinai Beth Israel, New York, New York

Search for more papers by this author
Erez Dayan MD

Erez Dayan MD

Division of Plastic Surgery, Mount Sinai Beth Israel, New York, New York

Search for more papers by this author
Diane S. Saint-Victor MPH

Diane S. Saint-Victor MPH

Division of Plastic Surgery, Mount Sinai Beth Israel, New York, New York

Search for more papers by this author
Julie N. Kim MD

Julie N. Kim MD

Division of Plastic Surgery, Mount Sinai Beth Israel, New York, New York

Search for more papers by this author
Eugene S. Kahn MD

Eugene S. Kahn MD

Division of Plastic Surgery, Mount Sinai Beth Israel, New York, New York

Search for more papers by this author
Alexander Kagen MD

Alexander Kagen MD

Department of Radiology, Mount Sinai Beth Israel, New York, New York

Search for more papers by this author
Joseph H. Dayan MD

Joseph H. Dayan MD

Division of Plastic Surgery, Memorial Sloan Kettering Cancer Center, New York, New York

Search for more papers by this author
First published: 15 December 2016
Citations: 23
Conflicts of interest: None.

Abstract

Background

The use of heterotopic vascularized lymph node transfer (HVLNT) for the treatment of lower extremity lymphedema is still evolving. Current techniques, either place the lymph nodes in the thigh without a skin paddle or at the ankle requiring an unsightly and often bulky skin paddle for closure. We explored the feasibility of doing a below-knee transfer without a skin paddle using the medial sural vessels as recipient vessels and report our experience in 21 patients.

Methods

A retrospective review of all patients who underwent HVLNT to the medial calf was performed. Postoperative magnetic resonance angiography (MRA) and lymphoscintigraphy (LS) were analyzed to assess lymph node viability and function after transfer.

Results

Twenty-one patients underwent HVLNT to the medial calf. Postoperative imaging was performed at an average of 11 months after surgery. Thirteen patients had postoperative MRA, of whom 12 demonstrated viable lymph nodes. Seven patients underwent postoperative LS, of whom three demonstrated uptake in the transferred nodes. In the other four patients, the injectate failed to reach the level of the proximal calf.

Conclusion

We provide proof of concept that HVLNT to the lower leg using the medial sural vessels without a skin paddle can result in viable and functional lymph nodes in the setting of lower extremity lymphedema. J. Surg. Oncol. 2017;115:90–95. © 2016 Wiley Periodicals, Inc.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.